GAMMA Investing’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$491K Buy
21,695
+13,687
+171% +$307K 0.02% 661
2026
Q1
$181K Sell
8,008
-915
-10% -$21K 0.01% 1196
2025
Q4
$213K Sell
8,923
-1,514
-15% -$37.7K 0.01% 997
2025
Q3
$275K Buy
10,437
+585
+6% +$15K 0.02% 776
2025
Q2
$281K Buy
9,852
+249
+3% +$6.68K 0.02% 704
2025
Q1
$239K Buy
9,603
+2,439
+34% +$58.1K 0.02% 686
2024
Q4
$162K Buy
7,164
+2,166
+43% +$47K 0.01% 795
2024
Q3
$106K Buy
4,998
+1,675
+50% +$33K 0.01% 961
2024
Q2
$63.4K Sell
3,323
-907
-21% -$18.5K 0.01% 1033
2024
Q1
$81.6K Buy
4,230
+758
+22% +$15K 0.02% 743
2023
Q4
$67K Buy
+3,472
New +$66.7K 0.02% 735

Other funds holding FMS

GAMMA Investing's FMS Position: Q2 2026 in Review

GAMMA Investing increased its Fresenius Medical Care (FMS) stake by 171% in Q2 2026, buying an estimated $307K and bringing the position to 21,695 shares worth $491K. The position accounts for 0.02% of the portfolio, ranked #661.

GAMMA Investing first reported a position in FMS in Q4 2023 and has held it in 11 quarters since. 38 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • GAMMA Investing held 21,695 shares of Fresenius Medical Care worth $491K as of Q2 2026.
  • GAMMA Investing bought 13,687 Fresenius Medical Care shares in Q2 2026, an estimated $307K.
  • Fresenius Medical Care made up 0.02% of GAMMA Investing's portfolio in Q2 2026, its #661 holding.
  • GAMMA Investing first reported a position in Fresenius Medical Care in Q4 2023 and has held it in 11 quarters since.
  • 38 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.